Emergent management of diabetic foot problems in the modern era: Improving outcomes

Troisi, Nicola; Bertagna, Giulia; Juszczak, Maciej; Canovaro, Francesco; Torri, Lorenzo; Adami, Daniele; Berchiolli, Raffaella Nice

doi:10.1053/j.semvascsurg.2023.04.012

Cited by 2 publications

(1 citation statement)

References 53 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Furthermore, time to revascularization is essential to achieve a successful outcome and to reduce tissue loss, as described by the statement “time is tissue” [ 13 ]. Second-level investigations may enlarge the time between diagnosis and treatment, so that several studies have already investigated the reliability of DUS for femoropopliteal and infrapopliteal lesions imaging [ 14 , 15 , 16 ].…”

Section: Introductionmentioning

confidence: 99%

Peripheral Interventional Strategy Assessment (PISA) for Diabetic Foot Ulcer Revascularization: Preliminary Outcomes of a Multidisciplinary Pilot Study

Berchiolli,

Bertagna,

Adami

et al. 2023

Diagnostics

Self Cite

View full text Add to dashboard Cite

Background: Digital subtraction angiography (DSA) still represents the gold standard for anatomical arterial mapping and revascularization decision-making in patients with chronic limb-threatening ischemia (CLTI), although DUS (Doppler Ultrasound) remains a primary non-invasive examination tool. The Global Vascular Guidelines established the importance of preoperative arterial mapping to guarantee an adequate in-line flow to the foot. The aim of this study was to evaluate the accuracy of DUS in guiding therapeutic vascular treatments on the basis of Global Vascular Guidelines without the need of a second-level examination. Methods: Between January 2022 and June 2022, all consecutive patients with CLTI to be revascularized underwent clinical examination and DUS without further diagnostic examinations. Primary outcomes assessed were technical success, and 30-day mortality. Secondary outcomes were 1-year amputation free survival, and time between evaluation and revascularization. Results: Sixty-eight patients with a mean age of 73.6 ± 8.5 years underwent lower limb revascularization. Technical success was 100%, and the 30-day mortality rate was 2.9%. Mean time between evaluation and revascularization was 29 ± 17 days. One-year amputation free survival was 97.1%. Conclusions: DUS without further diagnostic examinations can accurately assess the status of the vascular tree and foot runoff, providing enough information about target vessels to guide revascularization strategies.

show abstract